ReviewSubstance abuse and rehabilitation2015
New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.
Michael SoykaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it